4.6 Article

Binding Affinity via Docking: Fact and Fiction

期刊

MOLECULES
卷 23, 期 8, 页码 -

出版社

MDPI
DOI: 10.3390/molecules23081899

关键词

docking; solvent effect; binding affinity; scoring function; molecular dynamics

资金

  1. Academy of Finland [276509]
  2. Academy of Finland (AKA) [276509, 276509] Funding Source: Academy of Finland (AKA)

向作者/读者索取更多资源

In 1982, Kuntz et al. published an article with the title A Geometric Approach to Macromolecule-Ligand Interactions, where they described a method to explore geometrically feasible alignment of ligands and receptors of known structure. Since then, small molecule docking has been employed as a fast way to estimate the binding pose of a given compound within a specific target protein and also to predict binding affinity. Remarkably, the first docking method suggested by Kuntz and colleagues aimed to predict binding poses but very little was specified about binding affinity. This raises the question as to whether docking is the right tool to estimate binding affinity. The short answer is no, and this has been concluded in several comprehensive analyses. However, in this opinion paper we discuss several critical aspects that need to be reconsidered before a reliable binding affinity prediction through docking is realistic. These are not the only issues that need to be considered, but they are perhaps the most critical ones. We also consider that in spite of the huge efforts to enhance scoring functions, the accuracy of binding affinity predictions is perhaps only as good as it was 10-20 years ago. There are several underlying reasons for this poor performance and these are analyzed. In particular, we focus on the role of the solvent (water), the poor description of H-bonding and the lack of the systems' true dynamics. We hope to provide readers with potential insights and tools to overcome the challenging issues related to binding affinity prediction via docking.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Multidisciplinary Sciences

Decisive role of water and protein dynamics in residence time of p38α MAP kinase inhibitors

Tatu Pantsar, Philipp D. Kaiser, Mark Kudolo, Michael Forster, Ulrich Rothbauer, Stefan A. Laufer

Summary: Target residence time is crucial for the pharmacological activity of small molecule inhibitors. This study used molecular dynamics simulations to gain insight into the underlying causes of inhibitor residence time at the molecular level. The results highlight the importance of protein conformational stability, solvent exposure, buried surface area of the ligand, and binding site resolvation energy for residence time.

NATURE COMMUNICATIONS (2022)

Article Chemistry, Medicinal

Structure of POPC Lipid Bilayers in OPLS3e Force Field

Milla Kurki, Antti Poso, Piia Bartos, Markus S. Miettinen

Summary: This study investigates the impact of the OPLS3e force field on POPC bilayers under varying hydration and ion concentrations. The results demonstrate that OPLS3e performs similarly to CHARMM36, accurately simulating the behavior of lipid molecules. However, it overestimates the binding affinity of cations in ion-rich systems.

JOURNAL OF CHEMICAL INFORMATION AND MODELING (2022)

Article Chemistry, Medicinal

Do Go Chasing Waterfalls: Enoyl Reductase (FabI) in Complex with Inhibitors Stabilizes the Tetrameric Structure and Opens Water Channels

Vinicius Goncalves Maltarollo, Ekaterina Shevchenko, Igor Daniel de Miranda Lima, Elio A. Cino, Glaucio Monteiro Ferreira, Antti Poso, Thales Kronenberger

Summary: This study used molecular dynamics to investigate the effects of inhibitors on tetramerization of the enzyme FabI. The results suggest that multimerization is essential for the integrity of the catalytic site and that inhibitor binding enables multimerization by stabilizing the substrate binding loop. AFN-1252 induces unique conformational changes affecting monomer-monomer interfaces and allows more water molecules to enter the binding site.

JOURNAL OF CHEMICAL INFORMATION AND MODELING (2022)

Article Medicine, Research & Experimental

Sodium-Dependent Neutral Amino Acid Transporter 2 Can Serve as a Tertiary Carrier for L-Type Amino Acid Transporter 1-Utilizing Prodrugs

Johanna Huttunen, Thales Kronenberger, Ahmed B. Montaser, Adela Kralova, Tetsuya Terasaki, Antti Poso, Kristiina M. Huttunen

Summary: This study explored the interactions between L-type amino acid transporter 1 (LAT1)-utilizing prodrugs and sodium-coupled neutral amino acid transporter 2 (SNAT2). It was found that the cellular uptake of LAT1-utilizing prodrugs in MCF-7 cells was mediated by SNATs, which increased at higher pH, decreased in the absence of sodium, and was inhibited by a SNAT-inhibitor. Docking, molecular dynamics simulations, and analysis confirmed the chemical features supporting the interactions of the studied compounds with SNAT2.

MOLECULAR PHARMACEUTICS (2023)

Article Medicine, Research & Experimental

Structural Features Affecting the Interactions and Transportability of LAT1-Targeted Phenylalanine Drug Conjugates

Katayun Bahrami, Juulia Järvinen, Tuomo Laitinen, Mika Reinisalo, Paavo Honkakoski, Antti Poso, Kristiina M. Huttunen, Jarkko Rautio

Summary: In this study, a series of LAT1-targeted drug-phenylalanine conjugates were evaluated. Through in vitro studies and induced-fit docking, it was concluded that smaller compounds were preferred for uptake by LAT1. The flexibility of the ligand played a crucial role in determining the transportability and interactions with LAT1. Introducing polar groups enhanced interactions, while compounds with a carbamate bond in the para-position of the aromatic ring displayed efficient transport efficiencies. The findings of this study have implications for designing CNS or antineoplastic drug candidates and discovering LAT1 inhibitors for cancer therapy.

MOLECULAR PHARMACEUTICS (2023)

Article Chemistry, Medicinal

Amide-functionalized 1,2,4-Triazol-5-amines as Covalent Inhibitors of Blood Coagulation Factor XIIa and Thrombin

Lukas Imberg, Simon Platte, Catharina Erbacher, Constantin G. Daniliuc, Svetlana A. Kalinina, Wolfgang Doerner, Antti Poso, Uwe Karst, Dmitrii Kalinin

Summary: To combat thrombosis, we synthesized a series of amide-functionalized acylated 1,2,4-triazol-5-amines and found that one compound effectively inhibits FXIIa while another compound effectively inhibits thrombin. Mass-shift experiments and molecular modeling studies confirmed that the inhibition of FXIIa and thrombin by these compounds is through a covalent mechanism. In plasma coagulation tests, these compounds showed anticoagulant properties mainly affecting the intrinsic blood coagulation pathway associated with thrombosis but with minimal impact on hemostasis.

ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE (2022)

Article Chemistry, Medicinal

In Silico Evaluation of the Thr58-Associated Conserved Water with KRAS Switch-II Pocket Binders

Renne Leini, Tatu Pantsar

Summary: The KRAS SII-P is a successful tool for targeting KRAS with small molecules, as proven by the development of FDA-approved drugs and engagement with multiple mutants. A conserved water molecule in the pocket plays an important role, and its energetics and behavior were studied in the presence of inhibitors. The results highlight the significance of this water molecule in designing new inhibitors.

JOURNAL OF CHEMICAL INFORMATION AND MODELING (2023)

Article Chemistry, Medicinal

Design and Optimization of Novel Benzimidazole- and Imidazo[4,5-b]pyridine-Based ATM Kinase Inhibitors with Subnanomolar Activities

Teodor Dimitrov, Athina Anastasia Moschopoulou, Lennart Seidel, Thales Kronenberger, Mark Kudolo, Antti Poso, Christian Geibel, Pascal Woelffing, Daniel Dauch, Lars Zender, Dieter Schollmeyer, Juergen Bajorath, Michael Forster, Stefan Laufer

Summary: The ATM kinase is an important regulator of the cellular response to DNA double-strand breaks and is considered a promising target in cancer treatment. This study introduces a new class of specific benzimidazole-based ATM inhibitors with high potency against the isolated enzyme and favorable selectivity within related kinases. These inhibitors show strong enzymatic and cellular activities, as well as promising pharmacokinetic properties and selectivities within the PIKK and PI3K families.

JOURNAL OF MEDICINAL CHEMISTRY (2023)

Article Pharmacology & Pharmacy

Characterization of Potent ABCG2 Inhibitor Derived from Chromone: From the Mechanism of Inhibition to Human Extracellular Vesicles for Drug Delivery

Glaucio Valdameri, Diogo Henrique Kita, Julia de Paula Dutra, Diego Lima Gomes, Arun Kumar Tonduru, Thales Kronenberger, Bruno Gavinho, Izadora Volpato Rossi, Mariana Mazetto de Carvalho, Basile Peres, Ingrid Fatima Zattoni, Fabiane Gomes de Moraes Rego, Geraldo Picheth, Rilton Alves de Freitas, Antti Poso, Suresh V. Ambudkar, Marcel Ramirez, Ahcene Boumendjel, Vivian Rotuno Moure

Summary: Inhibition of ABC transporters is a promising strategy to overcome multidrug resistance in cancer. This study identified a potent ABCG2 inhibitor called chromone 4a (C4a) that exhibits selectivity towards ABCG2. C4a effectively inhibited the efflux of different substrates mediated by ABCG2 and showed potential for drug delivery using liposomes and extracellular vesicles (EVs) in overcoming poor water solubility.

PHARMACEUTICS (2023)

Article Chemistry, Medicinal

Trypanosoma cruzi Sirtuin 2 as a Relevant Druggable Target: New Inhibitors Developed by Computer-Aided Drug Design

Glaucio Monteiro Ferreira, Thales Kronenberger, Vinicius Goncalves Maltarollo, Antti Poso, Fernando de Moura Gatti, Vitor Medeiros Almeida, Sandro Roberto Marana, Carla Duque Lopes, Daiane Yukie Tezuka, Sergio de Albuquerque, Flavio da Silva Emery, Gustavo Henrique Goulart Trossini

Summary: The etiological agent of Chagas disease, Trypanosoma cruzi, relies on precise epigenetic regulation during host transitions. In this study, we used molecular modelling and experimental validation to discover new inhibitors from commercially available compound libraries. Six inhibitors were selected from virtual screening and validated on the recombinant Sir2 enzyme. The most potent inhibitor (CDMS-01, IC50 = 40 mu M) was chosen as a potential lead compound.

PHARMACEUTICALS (2023)

Article Chemistry, Medicinal

Machine Learning-Boosted Docking Enables the Efficient Structure-Based Virtual Screening of Giga-Scale Enumerated Chemical Libraries

Toni Sivula, Laxman Yetukuri, Tuomo Kalliokoski, Heikki Kasnanen, Antti Poso, Ina Pohner

Summary: The emergence of ultra-large screening libraries poses a challenge for docking-based virtual screening. Machine learning-boosted strategies like HASTEN combine rapid ML prediction with the brute-force docking to increase screening throughput. In our case study, we observed a significant reduction in docking experiments by 99% using HASTEN, resulting in shorter screening time.

JOURNAL OF CHEMICAL INFORMATION AND MODELING (2023)

Article Chemistry, Organic

Direct pathway cloning and expression of the radiosumin biosynthetic gene cluster

Xiaodan Ouyang, Paul M. D'Agostino, Matti Wahlsten, Endrews Delbaje, Jouni Jokela, Perttu Permi, Greta Gaiani, Antti Poso, Piia Bartos, Tobias A. M. Gulder, Hannu Koistinen, David P. Fewer

Summary: In this study, a comparative bioinformatic analysis was used to identify radiosumin biosynthetic gene clusters in the genomes of 13 filamentous cyanobacteria. The entire biosynthetic gene cluster was captured and expressed in Escherichia coli. High-resolution liquid chromatography-mass spectrometry, nuclear magnetic resonance spectroscopy, and chemical degradation analysis revealed the chemical structure of novel radiosumins produced by cyanobacteria. Radiosumin C was found to inhibit human trypsin isoforms selectively.

ORGANIC & BIOMOLECULAR CHEMISTRY (2023)

Article Chemistry, Medicinal

HDAC specificity and kinase off-targeting by purine-benzohydroxamate anti-hematological tumor agents

Karoline B. Waitman, Larissa C. de Almeida, Marina C. Primi, Jorge A. E. G. Carlos, Claudia Ruiz, Thales Kronenberger, Stefan Laufer, Marcia Ines Goettert, Antti Poso, Sandra V. Vassiliades, Vinicius A. M. de Souza, Monica F. Z. J. Toledo, Neuza M. A. Hassimotto, Michael D. Cameron, Thomas D. Bannister, Leticia Costa-Lotufo, Joa o A. Machado-Neto, Mauricio T. Tavares, Roberto Parise-Filho

Summary: A series of hybrid inhibitors combining pharmacophores of known kinase inhibitors and benzohydroxamate HDAC inhibitors were synthesized and evaluated for their anticancer activity and pharmacokinetic properties. Compounds 4d-f exhibited promising cytotoxicity against hematological cells and moderate activity against solid tumor models. Compound 4d showed potent inhibition of multiple kinase targets and had stable interactions with HDAC and members of the JAK family. These compounds showed selective cytotoxicity with minimal effects on non-tumorigenic cells and favorable pharmacokinetic profiles.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2024)

Article Chemistry, Medicinal

Discovery and Development of First-in-Class ACKR3/CXCR7 Superagonists for Platelet Degranulation Modulation

Alp Bayrak, Florian Mohr, Kyra Kolb, Martyna Szpakowska, Ekaterina Shevchenko, Valerie Dicenta, Anne-Katrin Rohlfing, Mark Kudolo, Tatu Pantsar, Marcel Guenther, Agnieszka A. Kaczor, Antti Poso, Andy Chevigne, Thanigaimalai Pillaiyar, Meinrad Gawaz, Stefan A. Laufer

Summary: This study reports the discovery and development of first-in-class ACKR3 agonists, which demonstrated superagonistic properties in a fi-arrestin recruitment assay. Through structure-activity relationship studies, novel compounds with selective activity against ACKR3 were identified, showing potential as candidates for the treatment of platelet-mediated thrombosis.

JOURNAL OF MEDICINAL CHEMISTRY (2022)

Article Biochemistry & Molecular Biology

Discrepancy in interactions and conformational dynamics of pregnane X receptor (PXR) bound to an agonist and a novel competitive

Azam Rashidian, Enni-Kaisa Mustonen, Thales Kronenberger, Matthias Schwab, Oliver Burk, Stefan A. Laufer, Tatu Pantsar

Summary: In this study, the authors used molecular dynamics simulations and experimental methods to investigate the mechanism of action of a newly identified compound 100 as a PXR antagonist. The results provide insights into the conformational changes in the PXR ligand binding domain induced by compound 100, and reveal the ligand-specific influence on different regions of PXR-LBD. This research is important for understanding the function of PXR and guiding drug design.

COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2022)

暂无数据